Results 1 to 16 of 16
Page 1 of 1
TypeTitleAuthor(s)YearViews
Impact of precore and core promoter mutations on hepatic histology in patients with chronic hepatitis BYuan, HJ; Yuen, MF; Wong, DKH; Sum, SM; Sablon, E; Ng, IOL; Lai, CL200598
 
Hepatic necroinflammation and fibrosis in patients with genotypes Ba and C, core-promoter and precore mutationsYuen, MF; Tanaka, Y; Ng, IOL; Mizokami, M; Yuen, JCH; Wong, DKH; Yuan, HJ; Sum, SM; Chan, AOO; Lai, CL2005102
 
Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearanceYuan, HJ; Yuen, MF; Wong, DKH; Sum, SM; Doutreloigne, J; Sablon, E; Lai, CL2005227
 
Role of hepatitis B virus genotypes Ba and C, core promoter and precore mutations on hepatocellular carcinoma: A case control studyYuen, MF; Tanaka, Y; Mizokami, M; Yuen, JCH; Wong, DKH; Yuan, HJ; Sum, SM; Chan, AOO; Wong, BCY; Lai, CL2004100
 
Effect of lamivudine therapy on the serum covalently closed circular DNA of chronic hepatitis B infection.Yuen, RMF; Wong, DKH; Sum, SM; Yuan, H; Yuen, JCH; Chan, OO; Wong, BCY; Lai, CL200465
 
Quantitation of HBV covalently closed circular DNA (HBV cccDNA) in HCC patients.Wong, DKH; Yuen, RMF; Poon, RTP; Sum, SM; Lai, CL200489
 
Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong KongYuen, MF; Sablon, E; Tanaka, Y; Kato, T; Mizokami, M; Doutreloigne, J; Yuan, HJ; Wong, DKH; Sum, SM; Lai, CL2004112
 
HBsAg seroclearance in Chinese patients receiving lamivudine therapy for chronic hepatitis B virus infectionYuen, MF; Wong, DKH; Yuan, HJ; Sum, SM; Lai, CL2004274
 
Longitudinal study of hepatitis activity and viral replication before and after HBeAg seroconversion in chronic hepatitis B patients infected with genotypes B and CYuen, MF; Fung, SK; Tanaka, Y; Kato, T; Mizokami, M; Yuen, JCH; Wong, DKH; Yuan, HJ; Sum, SM; Chan, AOO; Wong, BCY; Lai, CL2004265
 
Hepatitis B virus genotypes B and C do not affect the anti-viral response to lamivudineYuen, RMF; Wong, DKH; Sablon, E; Yuan, H; Sum, SM; Hui, CK; Chan, AOO; Wong, BCY; Lai, CL200386
 
A novel real-time PCR assay using molecular beacon (HBV Beacon Assay) for the quantitation of hepatitis B virus DNASum, SM; Wong, DKH; Yuen, RMF; Yuan, H; Yu, J; Lai, CL; Zhang, L; Ho, D2003150
 
Determinants for the occurrence of acute exacerbation after HBeAg seroclearance in Chinese patientsYuan, H; Yuen, RMF; Wong, DKH; Sum, SM; Doutreloigne, J; Sablon, E; Lai, CL200389
 
Determinants for the Occurrence of Acute Exacerbation after HBeAg Seroclearance in Chinese PatientsYuan, H; Yuen, MF; Wong, DKH; Sum, SM; Doutreloigne, J; Sablon, E; Lai, CL200388
 
Hepatitis B virus genotypes B and C do not affect the antiviral response to lamivudineYuen, MF; Wong, DKH; Sablon, E; Yuan, HJ; Sum, SM; Hui, CK; Chan, AOO; Wong, BCY; Lai, CL2003114
 
Hepatitis B Virus Genotypes B and C Do Not Affect the Anti-viral Response to LamivudineYuen, MF; Wong, DKH; Sablon, E; Yuan, H; Sum, SM; Hui, CK; Wong, BCY; Lai, CL200391
 
Clinical outcome and virologic profiles of severe hepatitis B exacerbation due to YMDD mutationsYuen, MF; Kato, T; Mizokami, M; Chan, AOO; Yuen, JCH; Yuan, HJ; Wong, DKH; Sum, SM; Ng, IOL; Fan, ST; Lai, CL2003174
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download